Skip to main content

On This Page

← AI Financial News

TTM Technologies – 2026-01-13 - Increase Confidence 8/10

2 min read $TTMI
Share

These articles are AI-generated summaries. Please check the original sources for full details.

TTMITTM Technologies, Inc.
$77.89+22.36 (+40.27%)
$80$68$55Oct 13Nov 25Jan 12
52W High: $80.2452W Low: $55.25Volume: 1.60M
NasdaqGS
Prediction (1/27/2026):High: $96.45Low: $15.77Ref Price: $93.24
This chart shows historical data as of January 12, 2026. Not updated in real-time.

TTMI – Increase in Days/Weeks

TTM Technologies reported 22% year-over-year sales growth and 40.9% EBIT growth in Q3 2025, signaling strong operational leverage. The company’s recent $100 million share repurchase program and expansion in Syracuse and Penang highlight confidence in sustained demand from AI data centers and defense contracts.

Why This Matters

TTM is strategically positioned at the intersection of two high-growth, capital-intensive sectors—AI infrastructure and defense electronics—both experiencing multi-year tailwinds. The company’s focus on high-performance PCBs and RF systems for advanced radar and data center applications aligns with rising government and private spending, making near-term revenue momentum likely to persist, even as valuation multiples remain elevated.

Key Insights

  • Financial Performance: Revenue of $2.78B (TTM), Net Income of $131.93M, 22% sales growth and 40.9% EBIT growth YoY in Q3 2025
  • News Impact: $100M share repurchase approved and capacity expansion underway, reinforcing confidence in future cash flows
  • Risk/Offset: High P/E of 74.0 and Beta of 1.745 increase volatility risk in a rising rate or risk-off environment

Practical Implications

  • Bull Case: Continued AI and defense momentum + buyback support → move toward $96.45 52-week high (+3.5%) in 2 weeks
  • Bear Case: Market-wide tech selloff or earnings miss due to macro pressures → potential pullback to $85 (-8.8%)
  • Confidence: 8/10 – Strong fundamentals and catalysts outweigh valuation concerns in short term

Prediction: increase

Reference:

Continue reading

Next article

Travere Therapeutics – 2026-01-13 - Decrease Confidence 7/10

Related Content